171 related articles for article (PubMed ID: 28217309)
1. QRS duration versus morphology and survival after cardiac resynchronization therapy.
Khidir MJ; Delgado V; Ajmone Marsan N; Schalij MJ; Bax JJ
ESC Heart Fail; 2017 Feb; 4(1):23-30. PubMed ID: 28217309
[TBL] [Abstract][Full Text] [Related]
2. QRS duration, bundle-branch block morphology, and outcomes among older patients with heart failure receiving cardiac resynchronization therapy.
Peterson PN; Greiner MA; Qualls LG; Al-Khatib SM; Curtis JP; Fonarow GC; Hammill SC; Heidenreich PA; Hammill BG; Piccini JP; Hernandez AF; Curtis LH; Masoudi FA
JAMA; 2013 Aug; 310(6):617-26. PubMed ID: 23942680
[TBL] [Abstract][Full Text] [Related]
3. Cardiac resynchronization therapy in women versus men: observational comparative effectiveness study from the National Cardiovascular Data Registry.
Zusterzeel R; Spatz ES; Curtis JP; Sanders WE; Selzman KA; Piña IL; Bao H; Ponirakis A; Varosy PD; Masoudi FA; Caños DA; Strauss DG
Circ Cardiovasc Qual Outcomes; 2015 Mar; 8(2 Suppl 1):S4-11. PubMed ID: 25714821
[TBL] [Abstract][Full Text] [Related]
4. Impact of QRS complex duration and morphology on left ventricular reverse remodelling and left ventricular function improvement after cardiac resynchronization therapy.
van der Bijl P; Khidir M; Leung M; Mertens B; Ajmone Marsan N; Delgado V; Bax JJ
Eur J Heart Fail; 2017 Sep; 19(9):1145-1151. PubMed ID: 28176418
[TBL] [Abstract][Full Text] [Related]
5. Cardiac Resynchronization Therapy Improves Outcomes in Patients With Intraventricular Conduction Delay But Not Right Bundle Branch Block: A Patient-Level Meta-Analysis of Randomized Controlled Trials.
Friedman DJ; Al-Khatib SM; Dalgaard F; Fudim M; Abraham WT; Cleland JGF; Curtis AB; Gold MR; Kutyifa V; Linde C; Tang AS; Ali-Ahmed F; Olivas-Martinez A; Inoue LYT; Sanders GD
Circulation; 2023 Mar; 147(10):812-823. PubMed ID: 36700426
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of Cardiac Resynchronization Therapy by QRS Morphology in the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT).
Zareba W; Klein H; Cygankiewicz I; Hall WJ; McNitt S; Brown M; Cannom D; Daubert JP; Eldar M; Gold MR; Goldberger JJ; Goldenberg I; Lichstein E; Pitschner H; Rashtian M; Solomon S; Viskin S; Wang P; Moss AJ;
Circulation; 2011 Mar; 123(10):1061-72. PubMed ID: 21357819
[TBL] [Abstract][Full Text] [Related]
7. New York Heart Association functional class, QRS duration, and survival in heart failure with reduced ejection fraction: implications for cardiac resychronization therapy.
Braunschweig F; Linde C; Benson L; Ståhlberg M; Dahlström U; Lund LH
Eur J Heart Fail; 2017 Mar; 19(3):366-376. PubMed ID: 27338764
[TBL] [Abstract][Full Text] [Related]
8. Machine Learning of 12-Lead QRS Waveforms to Identify Cardiac Resynchronization Therapy Patients With Differential Outcomes.
Feeny AK; Rickard J; Trulock KM; Patel D; Toro S; Moennich LA; Varma N; Niebauer MJ; Gorodeski EZ; Grimm RA; Barnard J; Madabhushi A; Chung MK
Circ Arrhythm Electrophysiol; 2020 Jul; 13(7):e008210. PubMed ID: 32538136
[TBL] [Abstract][Full Text] [Related]
9. QRS Area Is a Strong Determinant of Outcome in Cardiac Resynchronization Therapy.
van Stipdonk AMW; Ter Horst I; Kloosterman M; Engels EB; Rienstra M; Crijns HJGM; Vos MA; van Gelder IC; Prinzen FW; Meine M; Maass AH; Vernooy K
Circ Arrhythm Electrophysiol; 2018 Dec; 11(12):e006497. PubMed ID: 30541356
[TBL] [Abstract][Full Text] [Related]
10. Predicting response to cardiac resynchronization therapy: Use of strict left bundle branch block criteria.
Hadjis A; AlTurki A; Proietti R; Montemezzo M; Bernier M; Joza J; Hadjis T; Essebag V
Pacing Clin Electrophysiol; 2019 Apr; 42(4):431-438. PubMed ID: 30779177
[TBL] [Abstract][Full Text] [Related]
11. Sex-specific mortality risk by QRS morphology and duration in patients receiving CRT: results from the NCDR.
Zusterzeel R; Curtis JP; Caños DA; Sanders WE; Selzman KA; Piña IL; Spatz ES; Bao H; Ponirakis A; Varosy PD; Masoudi FA; Strauss DG
J Am Coll Cardiol; 2014 Sep; 64(9):887-94. PubMed ID: 25169173
[TBL] [Abstract][Full Text] [Related]
12. Relation of QRS Duration to Clinical Benefit of Cardiac Resynchronization Therapy in Mild Heart Failure Patients Without Left Bundle Branch Block: The Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy Substudy.
Biton Y; Kutyifa V; Cygankiewicz I; Goldenberg I; Klein H; McNitt S; Polonsky B; Ruwald AC; Ruwald MH; Moss AJ; Zareba W
Circ Heart Fail; 2016 Feb; 9(2):e002667. PubMed ID: 26823498
[TBL] [Abstract][Full Text] [Related]
13. Effect of QRS duration and morphology on cardiac resynchronization therapy outcomes in mild heart failure: results from the Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction (REVERSE) study.
Gold MR; Thébault C; Linde C; Abraham WT; Gerritse B; Ghio S; St John Sutton M; Daubert JC
Circulation; 2012 Aug; 126(7):822-9. PubMed ID: 22781424
[TBL] [Abstract][Full Text] [Related]
14. Stricter criteria for left bundle branch block diagnosis do not improve response to CRT.
Bertaglia E; Migliore F; Baritussio A; De Simone A; Reggiani A; Pecora D; D'Onofrio A; Rapacciuolo A; Savarese G; Pierantozzi A; Marenna B; Ruffa F; Campari M; Malacrida M; Stabile G
Pacing Clin Electrophysiol; 2017 Jul; 40(7):850-856. PubMed ID: 28543265
[TBL] [Abstract][Full Text] [Related]
15. Usefulness of echocardiographically guided left ventricular lead placement for cardiac resynchronization therapy in patients with intermediate QRS width and non-left bundle branch block morphology.
Marek JJ; Saba S; Onishi T; Ryo K; Schwartzman D; Adelstein EC; Gorcsan J
Am J Cardiol; 2014 Jan; 113(1):107-16. PubMed ID: 24169014
[TBL] [Abstract][Full Text] [Related]
16. Gender, underutilization of cardiac resynchronization therapy, and prognostic impact of QRS prolongation and left bundle branch block in heart failure.
Linde C; Ståhlberg M; Benson L; Braunschweig F; Edner M; Dahlström U; Alehagen U; Lund LH
Europace; 2015 Mar; 17(3):424-31. PubMed ID: 25164429
[TBL] [Abstract][Full Text] [Related]
17. Scar burden, not intraventricular conduction delay pattern, is associated with outcomes in ischemic cardiomyopathy patients receiving cardiac resynchronization therapy.
Adelstein EC; Althouse AD; Schwartzman D; Jain SK; Soman P; Saba S
Heart Rhythm; 2018 Nov; 15(11):1664-1672. PubMed ID: 29852239
[TBL] [Abstract][Full Text] [Related]
18. Differential response to cardiac resynchronization therapy and clinical outcomes according to QRS morphology and QRS duration.
Dupont M; Rickard J; Baranowski B; Varma N; Dresing T; Gabi A; Finucan M; Mullens W; Wilkoff BL; Tang WH
J Am Coll Cardiol; 2012 Aug; 60(7):592-8. PubMed ID: 22796255
[TBL] [Abstract][Full Text] [Related]
19. The relationship of QRS morphology and mechanical dyssynchrony to long-term outcome following cardiac resynchronization therapy.
Hara H; Oyenuga OA; Tanaka H; Adelstein EC; Onishi T; McNamara DM; Schwartzman D; Saba S; Gorcsan J
Eur Heart J; 2012 Nov; 33(21):2680-91. PubMed ID: 22351700
[TBL] [Abstract][Full Text] [Related]
20. Implantable Cardioverter-Defibrillators With Versus Without Resynchronization Therapy in Patients With a QRS Duration >180 ms.
Sundaram V; Sahadevan J; Waldo AL; Stukenborg GJ; Reddy YNV; Asirvatham SJ; Mackall JA; Intini A; Wilson B; Simon DI; Bilchick KC
J Am Coll Cardiol; 2017 Apr; 69(16):2026-2036. PubMed ID: 28427578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
